S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
The “Perfect Storm” for Gold (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
1970’s computer coder issues shocking A.I. warning (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
How to Know Which AI Company to Invest In… and When (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
The “Perfect Storm” for Gold (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
1970’s computer coder issues shocking A.I. warning (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
How to Know Which AI Company to Invest In… and When (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
The “Perfect Storm” for Gold (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
1970’s computer coder issues shocking A.I. warning (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
How to Know Which AI Company to Invest In… and When (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
The “Perfect Storm” for Gold (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
1970’s computer coder issues shocking A.I. warning (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
How to Know Which AI Company to Invest In… and When (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
Free Trial

Syros Pharmaceuticals (SYRS) Insider Trading & Ownership

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free syrs Stock Alerts
$5.56
+0.21 (+3.93%)
(As of 05:43 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Syros Pharmaceuticals (NASDAQ:SYRS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.45%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$4.00 M
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$57,016.75
Get SYRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Syros Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SYRS Insider Buying and Selling by Quarter

Ad Gold Safe Exchange
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Click here now to download the free Precious Metals Buying Guide!

Syros Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/2/2024David RothInsiderSell150$4.98$747.00  
12/21/2023Srinivas AkkarajuDirectorBuy904,977$4.42$3,999,998.34  
12/6/2023David RothInsiderSell6,287$3.95$24,833.65  
7/31/2023David RothInsiderSell7,348$3.95$29,024.60  
7/17/2023Eric R OlsonInsiderSell689$3.50$2,411.50  
(Data available from 1/1/2013 forward)

SYRS Insider Trading Activity - Frequently Asked Questions

Who is on Syros Pharmaceuticals's Insider Roster?

The list of insiders at Syros Pharmaceuticals includes David Roth, Eric R Olson, Srinivas Akkaraju, and Timothy Tyson. Learn more on insiders at SYRS.

What percentage of Syros Pharmaceuticals stock is owned by insiders?

10.45% of Syros Pharmaceuticals stock is owned by insiders. Learn more on SYRS's insider holdings.

Which Syros Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased SYRS shares in the last 24 months: Srinivas Akkaraju ($3,999,998.34), and Timothy Tyson ($16,771.04).

How much insider buying is happening at Syros Pharmaceuticals?

Insiders have purchased a total of 907,909 SYRS shares in the last 24 months for a total of $4,016,769.38 bought.

Which Syros Pharmaceuticals insiders have been selling company stock?

The following insiders have sold SYRS shares in the last 24 months: David Roth ($54,605.25), and Eric R Olson ($2,411.50).

How much insider selling is happening at Syros Pharmaceuticals?

Insiders have sold a total of 14,474 Syros Pharmaceuticals shares in the last 24 months for a total of $57,016.75 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:SYRS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The “Perfect Storm” for Gold
Gold Safe Exchange
1970’s computer coder issues shocking A.I. warning
TradeSmith
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
You won't believe what Citigroup just did to it's depositors
American Alternative
Options trading has suddenly become more reliable.
Eagle Publishing